Shelby Anderson, Ph.D.
Shelby Anderson brings more than 20 years of experience in various aspects of ADME and pharmaceutical R&D from early drug discovery through to clinical trial execution and commercialization. Prior to joining AIT Bioscience, she was site head, director of drug metabolism services for Q2 Solutions (previously Quintiles; previously Advion) in Indianapolis, IN. Her background includes roles at Lilly Research Laboratories (Eli Lilly) and Pfizer Research Division in the US and UK. She also spent time as an assistance professor of organic chemistry at Trinity College in Hartford, CT.
Anderson earned her BA in Chemistry from Carleton College, her Ph.D. in Organic Chemistry from Harvard University and completed her Postdoc work at Yale University.